Stock Quote        
  Join        Login  
logo

Markel (MKL) To Buy Alterra Capital (ALTE) For $3.13B

 December 19, 2012 09:43 AM
 

(By Balaseshan) Markel Corp. (NYSE: MKL), which markets and underwrites specialty insurance products, said it has agreed to buy Alterra Capital Holdings Ltd. (NASDAQ: ALTE) for about $3.13 billion, or $31 per share in cash and stock, to diversify into reinsurance.

Under the terms of the agreement, each Alterra common share will be converted into the right to receive 0.04315 Markel common shares (with cash paid for fractional shares) plus a cash payment of $10.

Following the merger, Markel's existing shareholders will own approximately 69% of the combined company on a fully diluted basis, with Alterra's shareholders owning approximately 31%.

The combination of Markel and Alterra is expected to create significant benefits for the shareholders of both companies, and to provide a robust foundation for strong financial performance going forward.

Following the close of the transaction, Markel is expected to write annual gross premiums of about $4.4 billion and to have about $6 billion in equity with capital flexibility to support future growth.

Complementary business profiles provide important diversification of risk, with Markel adding reinsurance and large-account insurance to its specialty insurance portfolio, the companies noted.

Following the close of the transaction, Markel's business is expected to be about 50% short-tail, 50% long tail; 67% insurance and 33% reinsurance.

The deal is expected to close in the first half of 2013.

Upon closing, two directors designated by Alterra's current board will be added to the board of directors of Markel.

MKL is trading down 4.45% at $464.43 on Wednesday, while ALTE trades 26.26% higher at $29.23.


Rich
i On The Market - Daily Newsletter
Every trading day, be ready to attack the market instead of reacting to the market.

You will know where the key technical resistance and support levels are and what the market is likely to do next. iStock will arm you with a target list of stocks to buy and sell - right now - based on our exclusive, proprietary trading models.

Two Week FREE Trial


Signup for i on the market daily edition


Advertisement

Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

Advertisement
Connect with iStockAnalyst
Popular Articles
Recent Research and Quote
Advertisement
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.